Effective January 29, 2024, Mr. Walter Tabaschek (“ Tabaschek ”) resigned as KeyStar Corp’s., a Nevada corporation (the “ Company ”) Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer and Treasurer.
On January 29, 2024, Mobivity Holdings Corp. (the “Company”) announced that Skye Fossey-Tomaske was appointed to serve as the Interim Chief Financial Officer of the Company, effective as of January 29, 2024.
On January 29, 2024, Will Sanchez and the Board of Directors (the “Board”) of Mobivity Holdings Corp. (the “Company”) have mutually agreed that Mr. Sanchez will end his employment as Chief Financial Officer of the Company.
On January 31, 2024, Rhinebeck Bancorp, Inc. (the “Company”), the holding company of Rhinebeck Bank, announced the retirement of Michael J. McDermott, Chief Financial Officer of the Company.
Departed
Jeff Hackman
President, Chief Executive Officer and Director
Comera Life Sciences Holdings, Inc.
Effective
2024-01-31
Successor
Michael Campbell
Filed
January 30, 2024, 6:59 PM ET
the Company terminated the employment of Jeff Hackman, President, Chief Executive Officer and Director, Michael Campbell, Executive Vice President and Chief Financial Officer, and Robert Mahoney, Chief Scientific Officer effective January 31, 2024.
Departed
Michael Campbell
Executive Vice President and Chief Financial Officer
Comera Life Sciences Holdings, Inc.
Effective
2024-01-31
Filed
January 30, 2024, 6:59 PM ET
the Company terminated the employment of Jeff Hackman, President, Chief Executive Officer and Director, Michael Campbell, Executive Vice President and Chief Financial Officer, and Robert Mahoney, Chief Scientific Officer effective January 31, 2024.
Appointed
Michael Campbell
Chief Executive Officer and Chief Financial Officer
Comera Life Sciences Holdings, Inc.
Effective
2024-01-31
Filed
January 30, 2024, 6:59 PM ET
the Company engaged Mr. Campbell as a consultant and appointed him to serve as the Company’s Chief Executive Officer and Chief Financial Officer effective immediately following the termination of his employment on January 31, 2024.
Departed
Samat Sultanalievich Nurmakhanov
Director, President, and CEO
China Solar & Clean Energy Solutions, Inc.
Effective
2023-12-28
Successor
Shelli Fields
Filed
January 30, 2024, 6:59 PM ET
On December 28, 2023, Samat Sultanalievich Nurmakhanov resigned from all positions, including Director, President, and CEO , of China Solar and Clean Energy Solutions, Inc. (the “Company”).
Appointed
Michael A. Marks
Executive Vice President and Chief Financial Officer
On January 30, 2024, the Company announced that Michael A. Marks, age 54, will succeed Mr. Rutherford as Executive Vice President and Chief Financial Officer, effective May 1, 2024.
Departed
William B. Rutherford
Executive Vice President and Chief Financial Officer
On January 24, 2024, William B. Rutherford notified the Company of his intent to retire from his position as Executive Vice President and Chief Financial Officer, effective May 1, 2024.
On January 29, 2024, the Board of Directors (the “Board”) of the Company appointed Todd Suko to serve as Interim Chief Financial Officer, effective February 1, 2024,
The RealReal, Inc. (the “Company”) previously announced the departure of Robert Julian, Chief Financial Officer, effective January 31, 2024.
Appointed
George England
Chief Executive Officer
Global Vision Holdings, Inc.
Effective
2024-01-30
Filed
January 30, 2024, 6:59 PM ET
Effective January 30, 2024, I Glen W. Carnes would like to inform you that I am resigning from my position as CEO and making way for “ George England” to take over as the new CEO of Global Vision Holdings, Inc.
Departed
Glen W. Carnes
Chief Executive Officer
Global Vision Holdings, Inc.
Effective
2024-01-30
Successor
George England
Filed
January 30, 2024, 6:59 PM ET
Effective January 30, 2024, I Glen W. Carnes would like to inform you that I am resigning from my position as CEO and making way for “ George England” to take over as the new CEO of Global Vision Holdings, Inc.
former Interim Chief Financial Officer, Fatima Dhalla, has resigned as the Interim Chief Financial Officer of the Company , effective January 19, 2024.
On January 24, 2024, the Board of Directors of Splash Beverage Group, Inc. (the “Company”) appointed Ms. Stacy McLaughlin to serve as Chief Financial Officer of the Company, effective as of the same date.
Appointed
Victoria Eatwell
Chief Financial Officer
2seventy bio, Inc.
Filed
January 30, 2024, 6:59 PM ET
On January 29, 2024, the Board appointed Victoria Eatwell as the chief financial officer of the Company, effective as of the date of the Closing.
Role change
Nick Leschly
President and Chief Executive Officer
2seventy bio, Inc.
Successor
William D. Baird, III
Filed
January 30, 2024, 6:59 PM ET
On January 29, 2024, Nick Leschly informed the Company of his resignation as the Company’s president and chief executive officer effective upon the date of the Closing.
Appointed
William D. Baird, III
President and Chief Executive Officer
2seventy bio, Inc.
Filed
January 30, 2024, 6:59 PM ET
On January 29, 2024, the Board appointed William D. Baird, III as the president and chief executive officer of the Company, effective as of the date of the Closing.
on January 22, 2024, the Company and Eric T. Kalamaras, the former Chief Financial Officer of the Company, agreed that Mr. Kalamaras’s employment would cease effective as of January 22, 2024.
On January 23, 2024, the Company’s Board of Directors approved the appointment of Mr. Evans, 50 years of age, to serve as the Company’s Chief Financial Officer.
Appointed
(interim)
Kevin Rubin
Chief Executive Officer
Alteryx, Inc.
Effective
2024-01-26
Filed
January 29, 2024, 6:59 PM ET
the Board appointed Kevin Rubin, age 49, and the Company's existing Chief Financial Officer, to become the Company's interim CEO, effective as of the Resignation Date.
Departed
Mark Anderson
Chief Executive Officer
Alteryx, Inc.
Effective
2024-01-26
Successor
Kevin Rubin
Filed
January 29, 2024, 6:59 PM ET
Mark Anderson, the Chief Executive Officer ("CEO") and a member of the Board of Directors (the "Board") of Alteryx, Inc. (the "Company"), resigned from his role as CEO and as a member of the Board, effective January 26, 2024
On January 29, 2024, TScan Therapeutics, Inc. (the “Company”) announced the appointment of Jason A. Amello as Chief Financial Officer, which was approved by the Board of Directors of the Company on January 24, 2024, effective January 29, 2024 (the “Start Date”).
Appointed
(interim)
Glen D. Weinstein
Interim Chief Executive Officer
IROBOT CORP
Effective
2024-01-28
Filed
January 29, 2024, 6:59 PM ET
Appointment of Interim Chief Executive Officer On January 28, 2024, the Board appointed Glen D. Weinstein as the Company’s Interim Chief Executive Officer.
Role change
Colin Angle
Chief Executive Officer
IROBOT CORP
Effective
2024-01-28
Successor
Glen D. Weinstein
Filed
January 29, 2024, 6:59 PM ET
On January 28, 2024, Colin Angle stepped down as Chief Executive Officer and chairman of the Board of Directors of the Company (“Board”).
Role change
Gerry P. Smith
Chief Executive Officer
ODP Corp
Effective
2024-02-01
Filed
January 29, 2024, 6:59 PM ET
Effective February 1, 2024, Mr. Smith will return from his medical leave and resume his duties and responsibilities as CEO of the Company.
Appointed
Milton C. Ault
Chief Executive Officer
RiskOn International, Inc.
Effective
2024-01-29
Filed
January 29, 2024, 6:59 PM ET
On the Effective Date, the Company appointed Mr. Ault as its Chairman of the Board as well as its Chief Executive Officer.
Departed
Jay Puchir
Chief Financial Officer
RiskOn International, Inc.
Effective
2024-01-29
Filed
January 29, 2024, 6:59 PM ET
and (ii) Jay Puchir, its former Chief Financial Officer
Departed
Randy May
Chief Executive Officer
RiskOn International, Inc.
Effective
2024-01-29
Successor
Milton C. Ault
Filed
January 29, 2024, 6:59 PM ET
the Company, accepted the resignations of (i) Randy May, its former Chairman of the Board of Directors (the “ Board ”) in such capacity, and as the Company’s Chief Executive Officer
On January 28, 2024, the board of directors (the “Board”) of Rocky Mountain Chocolate Factory (the “Company”) appointed Starlette B. Johnson to the position of Interim Chief Executive Officer, effective immediately.
On January 27, 2024, Robert Sarlls’ employment as Chief Executive Officer of the Company was terminated without Cause (as such term is defined in Mr. Sarlls’ offer letter with the Company, dated May 3, 2022, the “Sarlls Offer Letter”), effective immediately.
On January 25, 2024, the Company appointed Jennifer L. Callahan as the Company’s Senior Vice President and Chief Financial Officer, effective immediately.
On January 26, 2024, CytoDyn Inc., a Delaware corporation (the “Company”), entered into an employment agreement with Jacob P. Lalezari, M.D. (the “Employment Agreement”), under which he will be employed as the Company’s Chief Executive Officer and will serve as its principal executive officer, effective as of January 26, 2024.
On January 10, 2024, the Company entered into an agreement with Rapid Deployment LLC d/b/a InterimExecs (“InterimExecs”), under which Mitchell Cohen will serve as the Company’s Interim CFO, effective February 1, 2024.
On January 23, 2024, the Company accepted the letter of resignation of Jose Maria Eduardo Gonzalez Romero as a director of the Company and from all executive offices he held, including: Chief Executive Officer; Chief Financial Officer, President and Secretary, effective January 29, 2024.
Appointed
(interim)
Francis Pittilloni
Interim Chief Financial Officer, Principal Financial Officer and Chief Operations Officer
On January 29, 2024, the Company appointed Francis Pittilloni to be the Interim Chief Financial Officer, Principal Financial Officer and Chief Operations Officer.
Departed
Daniel Puckett
Chief Financial Officer
Shockwave Medical, Inc.
Effective
2024-02-05
Successor
Renee Gaeta
Filed
January 29, 2024, 6:59 PM ET
On January 29, 2024, Daniel Puckett resigned as Chief Financial Officer of the Company, effective as of the Effective Date.
Appointed
Renee Gaeta
Chief Financial Officer
Shockwave Medical, Inc.
Effective
2024-02-05
Filed
January 29, 2024, 6:59 PM ET
On January 28, 2024, the board of directors of Shockwave Medical, Inc. (the “Company”) appointed Renee Gaeta as Chief Financial Officer and to act as the Company’s principal financial officer for Securities and Exchange Commission (“SEC”) reporting purposes, effective as of February 5, 2024 (the “Effective Date”).
Appointed
Colin Ellis
Chief Financial Officer
Fintech Scion Ltd
Effective
2023-12-27
Filed
January 29, 2024, 6:59 PM ET
On December 27, 2023, the Board appointed Colin Ellis as Chief Financial Officer of the Company.
Departed
Shalom Dodoun
Chief Executive Officer
Fintech Scion Ltd
Effective
2023-12-27
Successor
Lim Chun Hoo
Filed
January 29, 2024, 6:59 PM ET
On December 27, 2023, the Board of Directors (the “Board”) of Fintech Scion Limited (the “Company”) accepted the resignation of Shalom Dodoun, the Chief Executive Officer of the Company, effective immediately (the “Separation Date”).
As previously disclosed, Mr. Garutti has informed the Company’s Board of Directors that he will retire from the Company in 2024 as its Chief Executive Officer and as an executive Board member upon the selection of his successor, but that he will serve as an advisor following this time through the end of 2024 to ensure a proper transition.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.